NCT03911388 2026-02-17HSV G207 in Children With Recurrent or Refractory Cerebellar Brain TumorsM.D. Anderson Cancer CenterPhase 1 Recruiting24 enrolled
NCT06357377 2026-01-14A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain TumorsNeonc Technologies, Inc.Phase 1 Not yet recruiting12 enrolled
NCT03500991 2025-12-17HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS TumorsSeattle Children's HospitalPhase 1 Active not recruiting10 enrolled
NCT03638167 2025-12-17EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS TumorsSeattle Children's HospitalPhase 1 Completed11 enrolled
NCT04185038 2025-12-15Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System TumorsSeattle Children's HospitalPhase 1 Recruiting90 enrolled